Anthony P Bihl III has bought stock on 6 days since May 2019

Anthony (Tony) P. Bihl III is a healthcare industry executive and corporate insider who has served as Interim Chief Executive Officer of Bioventus Inc. (BVS), returning to lead the company after previously serving as CEO and a member of the Board of Managers of Bioventus LLC from 2013 until his retirement in 2020.( He brings more than 35 years of experience in medical devices and diagnostics, and currently holds board roles at companies including Sonendo Inc. and Spectral Medical Inc., among others.( As interim CEO, he oversaw Bioventus during a leadership transition while also continuing to be a significant shareholder in the company.(

Earlier in his career, Bihl was CEO and President of American Medical Systems (AMS), where he led a major restructuring, built a performance-based culture, and guided the company’s successful sale to Endo Pharmaceuticals in 2011.( He previously served as CEO of Siemens Medical Solutions Diagnostics, forming and integrating a global diagnostics division, and as President and Executive Vice President of the diagnostics division of Bayer HealthCare LLC, where he managed the discussions and due diligence leading to its $5.4 billion sale to Siemens.( Before these roles, he held management positions at Sterling Diagnostic Imaging and E.I. DuPont.( Bihl holds a Bachelor of Science in business administration, with distinction, from Pennsylvania State University.(

Written by Perplexity from public sources.